Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Buprenorphine for Opioid Use Disorder: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines [Internet]

Dave K. Marchand, Calvin Young, Hannah Loshak
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Apr 24.
CADTH Rapid Response Reports.
Review

Buprenorphine for Opioid Use Disorder: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines [Internet]

Dave K. Marchand et al.

Excerpt

CADTH has previously reviewed the evidence for the use of buprenorphine formulations for the treatment of opioid use disorders (OUDs). One report was limited to pregnant populations, another was a qualitative review of patient preferences and perspectives, and the third was a summary of abstracts based on evidence available in 2017. The objective of the current report is to evaluate the comparative clinical effectiveness, safety, cost-effectiveness and evidencebased guidelines regarding various buprenorphine or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD.

PubMed Disclaimer

Grants and funding

Funding: CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.